Brazilian health authorities, through the National Health Surveillance Agency (Avinsa), approved the registration of the first chikungunya vaccine.
This achievement stems from the research work of the Brazilian Butantan Institute, the largest public vaccine manufacturer in Latin America, in…
Read More...
